TW200811150A - N-oxides of pyridylmethylpiperazine and -piperidine derivatives - Google Patents

N-oxides of pyridylmethylpiperazine and -piperidine derivatives Download PDF

Info

Publication number
TW200811150A
TW200811150A TW096115482A TW96115482A TW200811150A TW 200811150 A TW200811150 A TW 200811150A TW 096115482 A TW096115482 A TW 096115482A TW 96115482 A TW96115482 A TW 96115482A TW 200811150 A TW200811150 A TW 200811150A
Authority
TW
Taiwan
Prior art keywords
compound
oxide
formula
nitrogen atom
oxides
Prior art date
Application number
TW096115482A
Other languages
English (en)
Chinese (zh)
Inventor
Aar Marcel P M Van
Amsterdam Peter H Van
Gerrit A Barf
Johan Antoine Bakker
Besten Cathaline Den
Arnoldus H J Herremans
Jan Zorgdrager
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37198739&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200811150(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of TW200811150A publication Critical patent/TW200811150A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW096115482A 2006-05-02 2007-05-01 N-oxides of pyridylmethylpiperazine and -piperidine derivatives TW200811150A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06113393 2006-05-02

Publications (1)

Publication Number Publication Date
TW200811150A true TW200811150A (en) 2008-03-01

Family

ID=37198739

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096115482A TW200811150A (en) 2006-05-02 2007-05-01 N-oxides of pyridylmethylpiperazine and -piperidine derivatives

Country Status (16)

Country Link
EP (1) EP2024363B1 (enExample)
JP (1) JP2009535374A (enExample)
CN (1) CN101432279A (enExample)
AR (1) AR060832A1 (enExample)
AU (1) AU2007247251B2 (enExample)
BR (1) BRPI0710792A2 (enExample)
CA (1) CA2649479A1 (enExample)
CL (1) CL2007001245A1 (enExample)
EA (1) EA200870492A1 (enExample)
MX (1) MX2008013887A (enExample)
PE (1) PE20080064A1 (enExample)
SA (1) SA07280218B1 (enExample)
TW (1) TW200811150A (enExample)
UA (1) UA96756C2 (enExample)
WO (1) WO2007128694A1 (enExample)
ZA (1) ZA200809112B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101711236B (zh) * 2007-04-12 2012-10-31 Nsab神经研究瑞典公司分公司 表现出改善的心血管副作用特性的多巴胺受体稳定剂/调节剂的n-氧化物和/或二-n-氧化物衍生物
MX347209B (es) 2011-12-08 2017-04-19 Teva Pharmaceuticals Int Gmbh La sal de bromhidrato de pridopidina.
AU2013243461A1 (en) 2012-04-04 2014-11-06 Teva Pharmaceuticals International Gmbh Pharmaceutical compositions for combination therapy
GB201801128D0 (en) 2018-01-24 2018-03-07 Univ Oxford Innovation Ltd Compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3586794T2 (de) 1984-12-21 1993-05-27 Duphar Int Res Arzneimittel mit psychotroper wirkung.
TW530054B (en) 1997-09-24 2003-05-01 Duphar Int Res New piperazine and piperidine compounds

Also Published As

Publication number Publication date
JP2009535374A (ja) 2009-10-01
UA96756C2 (en) 2011-12-12
AR060832A1 (es) 2008-07-16
CA2649479A1 (en) 2007-11-15
MX2008013887A (es) 2009-01-29
AU2007247251A1 (en) 2007-11-15
BRPI0710792A2 (pt) 2011-06-21
EP2024363B1 (en) 2012-08-01
EA200870492A1 (ru) 2009-04-28
ZA200809112B (en) 2009-07-29
WO2007128694A1 (en) 2007-11-15
CL2007001245A1 (es) 2008-05-30
AU2007247251B2 (en) 2011-11-03
SA07280218B1 (ar) 2010-10-03
EP2024363A1 (en) 2009-02-18
PE20080064A1 (es) 2008-03-19
CN101432279A (zh) 2009-05-13

Similar Documents

Publication Publication Date Title
TWI327142B (en) Substituted bicyclic and tricyclic thrombin receptor antagonists
TWI404715B (zh) 二芳基醚脲化合物
TWI500622B (zh) 雜環衍生物
TW201004939A (en) Novel compounds
KR102498741B1 (ko) 질환 치료용 이-치환된 피라졸 화합물
JP2009514837A (ja) グルコキナーゼ調節物質としてのトリシクロ置換アミド
EA025322B1 (ru) Производные дигидробензооксазина и дигидропиридооксазина
WO2003062233A1 (en) 2-acylaminothiazole derivative or salt thereof
JP2008519083A (ja) アミノキナゾリン化合物
JPS61236764A (ja) 新規なインドール誘導体およびその酸付加塩ならびにそれらを含有する精神病治療剤
TW201040141A (en) Isothiourea derivatives or isourea derivatives having BACE1 inhibitory activity
JP2009514836A (ja) トリシクロ置換型アミド
TW201141855A (en) Compounds that modulate intracellular calcium
JP2009514835A (ja) トリシクロ置換型アミド
WO2011093501A1 (ja) Ｇｐｒ１１９作動薬
JP6689856B2 (ja) ６，７−ジヒドロピラゾロ［１，５−ａ］ピラジン−４（５Ｈ）−オン化合物およびＭＧＬＵＲ２受容体の負のアロステリック調節因子としてのそれらの使用
CN101686979A (zh) 脂肪酸酰胺水解酶的杂芳基取代的脲调节剂
CZ477799A3 (cs) Polymorfní forma 2-(R)-(1-(R)-(3,5-bis(trifluormetyl)fenyl)etoxy)-3-(S)-(4-fluor)fenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazol)metyl-morfolinu s antagonistickým účinkem na tachykininové receptory
TW200804353A (en) Pyrazine derivatives
BR112017019805B1 (pt) Composto, composição farmacêutica, e uso para fabricar uma composição farmacêutica para melhorar, prevenir ou tratar dor, ansiedade ou depressão, mal de parkinson, polaquiúria ou incontinência urinária e glaucoma
KR20130122531A (ko) Ｍｇｌｕｒ５ 양성 알로스테릭 조절물로서 치환된 ６­메틸니코틴아미드
JP2001513764A (ja) ５−ｈｔ２ａ拮抗剤としてのオキサゾリジン類
AU2007247251B2 (en) N-oxides of pyridylmethylpiperazine and -piperidine derivatives
EA017007B1 (ru) Соединения 5-(гетероциклил)алкил-n-(арилсульфонил)индола и их применение в качестве лигандов 5-ht
WO2021127459A1 (en) Gpr139 receptor modulators